ORMP

Conviction 51HealthcareScan · Thu, Sep 24, 2026

Oramed Pharmaceuticals Inc. (ORMP) closed at $4.78 (+1.27%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 53, RS Rating 91, -10.5% from its 52-week high, +64.3% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

ORMP$4.78+1.27%

ResistanceSupportVol 14Congress buyCongress sell

Vol MA14 237.45K

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

ORAMED PHARMACEUTICALS INC.PHARMACEUTICAL PREPARATIONSwww.oramed.com ↗

Price4.78

Change+1.27%

Gap+0.85%

Rel volume—

Avg volume231.48K

Avg $ vol1.12M

SMA 204.82

SMA 504.56

SMA 2003.87

Price vs 50+4.91%

Price vs 200+23.48%

MA stackbullish

50/200 cross—

Supertrendup · 4.59

RSI (14)53

MACD hist-0.03

MACD cross—

Stoch %K / %D47 / 38

ADX (14)17

+DI / −DI21 / 17

RSI divergence—

MACD divergence—

ATR %3.90%

ADR %3.86%

52w high5.34

52w low2.19

From 52w high-10.49%

Above 52w low+118.26%

New 52w highNo

SqueezeOff

Bollinger width13.02%

%B0.43

Donchian pos25.81%

Donchian high5.47

Donchian low4.54

AVWAP (52w high)4.83

vs AVWAP high-1.10%

AVWAP (52w low)3.91

vs AVWAP low+22.35%

OBV trendFlat

Chaikin MF (20)-0.02

Today vs 20d—

Avg vol (14d)237.45K

Avg vol (20d)231.48K

Avg $ vol (20d)1.12M

Market cap198.84M

RS Rating91 / 99

RS 3m (vs SPY)-8.89%

RS 6m (vs SPY)+19.75%

RS line new highNo

Trend template7/8

Technical rank79.7

1 week+2.36%

1 month-8.25%

3 months-4.40%

6 months+36.57%

1 year+91.97%

YTD+64.26%

P/E3.10

P/B1.00

P/S99.42

P/FCF-21.72

EPS1.50

Div yield—

ROE32.07%

ROA17.33%

Debt/Eq0.53

Current4.98

EV/EBITDA-19.24

Gross margin0.65%

Net margin—

Rev growth49.25%

EPS growth436.04%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value290.17M

Revenue2M

Net income78.16M

Gross profit13K

Free cash flow-9.15M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out40.93M

Employees13

ListedMon, Apr 19, 2004

Free float32.31M

Float %81.2%

Short interest1.15M

Days to cover4.3d

Short volume51.7%

Squeeze score36 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction51 / 100

Pattern quality—

Tech rank79.7 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance5.31

Support4.35

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ORMP · 1 recent

All disclosures →

Member	Side	Amount	Traded	Filed	PTR
Brad Knott house · R · NC · traded 2025-01-10	Sell	$15K–$50K	2025-01-10	2025-02-25	PDF

Insider activity

SEC Form 4 transactions in ORMP

No recent insider (Form 4) filings in ORMP. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in ORMP · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.